Potent Dengue Virus Neutralization by a Therapeutic Antibody with Low Monovalent Affinity Requires Bivalent Engagement

We recently described our most potently neutralizing monoclonal antibody, E106, which protected against lethal Dengue virus type 1 (DENV-1) infection in mice. To further understand its functional properties, we determined the crystal structure of E106 Fab in complex with domain III (DIII) of DENV-1 envelope (E) protein to 2.45 Å resolution. Analysis of the complex revealed a small antibody-antigen interface with the epitope on DIII composed of nine residues along the lateral ridge and A-strand regions. Despite strong virus neutralizing activity of E106 IgG at picomolar concentrations, E106 Fab exhibited a ∼20,000-fold decrease in virus neutralization and bound isolated DIII, E, or viral particles with only a micromolar monovalent affinity. In comparison, E106 IgG bound DENV-1 virions with nanomolar avidity. The E106 epitope appears readily accessible on virions, as neutralization was largely temperature-independent. Collectively, our data suggest that E106 neutralizes DENV-1 infection through bivalent engagement of adjacent DIII subunits on a single virion. The isolation of anti-flavivirus antibodies that require bivalent binding to inhibit infection efficiently may be a rare event due to the unique icosahedral arrangement of envelope proteins on the virion surface.

[1]  T. Baker,et al.  Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Diamond,et al.  Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions , 2012, Proceedings of the National Academy of Sciences.

[3]  E. Padlan,et al.  Antibody-antigen complexes. , 1988, Annual review of biochemistry.

[4]  T. Pierson,et al.  Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization , 2008, PLoS pathogens.

[5]  G. Ebel,et al.  Complex phenotypes in mosquitoes and mice associated with neutralization escape of a Dengue virus type 1 monoclonal antibody. , 2012, Virology.

[6]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[7]  R. Rico-Hesse,et al.  Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2 , 2010, Journal of Virology.

[8]  Y. Modis,et al.  Structure of the dengue virus envelope protein after membrane fusion , 2004, Nature.

[9]  Chris Doane,et al.  Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus , 2005, Nature Medicine.

[10]  Suh-Chin Wu,et al.  Structural Basis of a Flavivirus Recognized by Its Neutralizing Antibody , 2003, Journal of Biological Chemistry.

[11]  Soila Sukupolvi-Petty,et al.  Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype. , 2009, Virology.

[12]  M. Diamond,et al.  Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354 , 2010, Proceedings of the National Academy of Sciences.

[13]  S. Pillemer,et al.  Safety and Pharmacokinetics of Single Intravenous Dose of MGAWN1, a Novel Monoclonal Antibody to West Nile Virus , 2010, Antimicrobial Agents and Chemotherapy.

[14]  D. Blaas,et al.  Structure of a neutralizing antibody bound bivalently to human rhinovirus 2. , 1996, The EMBO journal.

[15]  D. Fremont,et al.  A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes , 2009, PLoS pathogens.

[16]  Maxim N. Artyomov,et al.  Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation , 2010, Nature.

[17]  Elena Zaitseva,et al.  Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus , 2012, The EMBO journal.

[18]  Michael S. Diamond,et al.  Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope , 2012, PLoS pathogens.

[19]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[20]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[21]  Gregory D. Gromowski,et al.  Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. , 2007, Virology.

[22]  S. Harrison,et al.  The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.

[23]  R. Rico-Hesse,et al.  Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. , 1990, Virology.

[24]  J. Roehrig,et al.  Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. , 1998, Virology.

[25]  K. Stiasny,et al.  Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites , 2006, Journal of Virology.

[26]  A. Thomas,et al.  Relationship between poliovirus neutralization and aggregation , 1986, Journal of virology.

[27]  Kenneth G. C. Smith,et al.  The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody , 2012, Science Translational Medicine.

[28]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[29]  T. Oliphant,et al.  Structural basis of West Nile virus neutralization by a therapeutic antibody , 2005, Nature.

[30]  Jiaqi Wang,et al.  Structural Changes in Dengue Virus When Exposed to a Temperature of 37°C , 2013, Journal of Virology.

[31]  A. Sabin.  Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.

[32]  Pejman Rohani,et al.  Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity , 2013, Journal of The Royal Society Interface.

[33]  C. Midgley,et al.  Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity , 2012, The Journal of Immunology.

[34]  Soila Sukupolvi-Petty,et al.  Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3 , 2010, Journal of Virology.

[35]  Anastassis Perrakis,et al.  Developments in the CCP4 molecular-graphics project. , 2004, Acta crystallographica. Section D, Biological crystallography.

[36]  T. Pierson,et al.  Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step , 2009, Journal of Virology.

[37]  Y. Modis,et al.  A ligand-binding pocket in the dengue virus envelope glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[39]  T. Pierson,et al.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. , 2008, Virology.

[40]  Richard J Kuhn,et al.  Dengue structure differs at the temperatures of its human and mosquito hosts , 2013, Proceedings of the National Academy of Sciences.

[41]  H. Wolfson,et al.  Shape complementarity at protein–protein interfaces , 1994, Biopolymers.

[42]  R. Mariuzza,et al.  Molecular recognition in antibody-antigen complexes. , 2002, Advances in protein chemistry.

[43]  Ralph S. Baric,et al.  Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses , 2010, PLoS pathogens.

[44]  G. Nybakken,et al.  Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody , 2009, The EMBO journal.

[45]  T S Baker,et al.  Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody , 1993, Journal of virology.

[46]  Wei Zhang,et al.  Structure of Dengue Virus Implications for Flavivirus Organization, Maturation, and Fusion , 2002, Cell.

[47]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[48]  D. Fremont,et al.  Capturing a Flavivirus Pre-Fusion Intermediate , 2009, PLoS pathogens.

[49]  Q. Sattentau,et al.  Occupancy and mechanism in antibody-mediated neutralization of animal viruses. , 2002, The Journal of general virology.

[50]  D. Fremont,et al.  Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. , 2008, Cell host & microbe.

[51]  Ying Zhang,et al.  Visualization of membrane protein domains by cryo-electron microscopy of dengue virus , 2003, Nature Structural Biology.

[52]  J. Novotný,et al.  Distances between the antigen-binding sites of three murine antibody subclasses measured using neutron and X-ray scattering. , 1992, Biochemistry.

[53]  G. Nybakken,et al.  West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody , 2006, Proceedings of the National Academy of Sciences.

[54]  E. Harris,et al.  Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes , 2011, PloS one.

[55]  S. Halstead,et al.  Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. , 1989, Reviews of infectious diseases.

[56]  J. Stephenson,et al.  Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments. , 1997, The Journal of general virology.

[57]  C. Nelson,et al.  The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 , 2010, PLoS pathogens.

[58]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[59]  T. Pierson,et al.  A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus , 2011, PLoS pathogens.

[60]  E. Hewat,et al.  Bivalent binding of a neutralising antibody to a calicivirus involves the torsional flexibility of the antibody hinge. , 1997, Journal of molecular biology.

[61]  Edward C Holmes,et al.  The origin, emergence and evolutionary genetics of dengue virus. , 2003, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[62]  J. Lifson,et al.  Distribution and three-dimensional structure of AIDS virus envelope spikes , 2006, Nature.

[63]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[64]  Richard J Kuhn,et al.  Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins , 2008, Nature Structural &Molecular Biology.

[65]  Hugues Bedouelle,et al.  Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. , 2012, Structure.